<p>Avacta Group Plc (LON:AVCT - 获取免费报告) 的股价在周三交易中下跌了 14.6%。该公司的股价最低曾达到 66.40 便士，最后交易价为 67.50 便士。在午间交易中，约有 4,507,580 股成交，较日均成交量 2,250,242 股增加了 100%。该股票此前收盘价为 79 便士。</p>
<h2>华尔街分析师观点</h2>
<p>另外，Peel Hunt 在 10 月 13 日的研究报告中重申了对 Avacta Group 的 “买入” 评级，并设定了 99 便士的目标价。根据 MarketBeat 的数据，一位股票研究分析师对该股票给予了买入评级，目前该公司的共识评级为 “买入”，平均目标价为 99 便士。</p>
<p><strong>查看我们关于 AVCT 的最新研究报告</strong></p>
<h2>Avacta Group 价格表现</h2>
<p>该公司的市值为 3.0487 亿英镑，市盈率为-4.01，贝塔值为 1.12。公司的债务与股本比率为 52.53，速动比率为 4.96，流动比率为 1.29。该股票的 50 日移动平均价格为 73.83 便士，200 日移动平均价格为 54.95 便士。</p>
<p>Avacta Group (LON:AVCT - 获取免费报告) 最近于 9 月 30 日发布了季度财报。这家生物技术公司报告该季度每股收益为-4.46 便士。Avacta Group 的股本回报率为-74.00%，净利润率为-114.45%。股票分析师预测 Avacta Group Plc 在本年度的每股收益将为-9.9011833 便士。</p>
<h2>Avacta Group 公司简介</h2>
<p>(获取免费报告)</p>
<p>Avacta Therapeutics 是一家临床阶段的生物制药公司，挑战当前的药物递送方法，以扩大高效癌症治疗药物的应用。该公司受益于世界一流的研发设施、团队中极具才华的科学家以及经验丰富的管理团队，成员分布在伦敦总部和美国。我们的专有 pre|CISION®平台通过将毒性药物结合到一种仅能被肿瘤特异性蛋白酶（成纤维细胞活化蛋白 FAP）切割的短肽上，从而掩盖毒性药物。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，优于 Avacta Group</li>
<li>如何投资科技股及值得考虑的顶级科技股</li>
<li>为什么台湾半导体的 6.5% 下跌可能是一个明智的买入机会</li>
<li>值得考虑的 5 只高评级分红股票</li>
<li>RTX 因国防订单激增而飙升至历史新高</li>
<li>如何有效使用 MarketBeat 评级筛选器</li>
<li>聪明的钱正在购买汽车供应商，而不是汽车品牌</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Avacta Group 吗？</h2>
<p>在考虑 Avacta Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Avacta Group 并不在名单上。</p>
<p>虽然 Avacta Group 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Avacta Group Plc（伦敦证券交易所代码：AVCT）的股价在周三下跌了 14.6%，至 67.50 便士，交易量是平均水平的两倍。尽管股价下跌，Peel Hunt 仍维持 “买入” 评级，目标价为 99 便士。该公司报告了本季度每股收益为负的 4.46 便士，并面临重大财务挑战。Avacta 专注于生物制药，利用其专有的 pre|CISION®平台专注于癌症治疗</p>

<p>Avacta Group Plc (LON:AVCT - Get Free Report)'s share price dropped 14.6% during trading on Wednesday . The company traded as low as GBX 66.40 and last traded at GBX 67.50. Approximately 4,507,580 shares changed hands during mid-day trading, an increase of 100% from the average daily volume of 2,250,242 shares. The stock had previously closed at GBX 79.</p>
<div class="lb-trans"><p>Avacta Group Plc (LON:AVCT - 获取免费报告) 的股价在周三交易中下跌了 14.6%。该公司的股价最低曾达到 66.40 便士，最后交易价为 67.50 便士。在午间交易中，约有 4,507,580 股成交，较日均成交量 2,250,242 股增加了 100%。该股票此前收盘价为 79 便士。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Separately, Peel Hunt restated a &#34;buy&#34; rating and set a GBX 99 price objective on shares of Avacta Group in a research report on Monday, October 13th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of &#34;Buy&#34; and an average price target of GBX 99.</p>
<div class="lb-trans"><p>另外，Peel Hunt 在 10 月 13 日的研究报告中重申了对 Avacta Group 的 “买入” 评级，并设定了 99 便士的目标价。根据 MarketBeat 的数据，一位股票研究分析师对该股票给予了买入评级，目前该公司的共识评级为 “买入”，平均目标价为 99 便士。</p>
</div><p><strong>View Our Latest Research Report on AVCT</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 AVCT 的最新研究报告</strong></p>
</div><h2>Avacta Group Price Performance</h2>
<div class="lb-trans"><h2>Avacta Group 价格表现</h2>
</div><p>The company has a market capitalization of £304.87 million, a PE ratio of -4.01 and a beta of 1.12. The company has a debt-to-equity ratio of 52.53, a quick ratio of 4.96 and a current ratio of 1.29. The stock has a 50 day moving average price of GBX 73.83 and a two-hundred day moving average price of GBX 54.95.</p>
<div class="lb-trans"><p>该公司的市值为 3.0487 亿英镑，市盈率为-4.01，贝塔值为 1.12。公司的债务与股本比率为 52.53，速动比率为 4.96，流动比率为 1.29。该股票的 50 日移动平均价格为 73.83 便士，200 日移动平均价格为 54.95 便士。</p>
</div><p>Avacta Group (LON:AVCT - Get Free Report) last released its quarterly earnings data on Tuesday, September 30th. The biotechnology company reported GBX (4.46) EPS for the quarter. Avacta Group had a negative return on equity of 74.00% and a negative net margin of 114.45%. Equities analysts forecast that Avacta Group Plc will post -9.9011833 earnings per share for the current year.</p>
<div class="lb-trans"><p>Avacta Group (LON:AVCT - 获取免费报告) 最近于 9 月 30 日发布了季度财报。这家生物技术公司报告该季度每股收益为-4.46 便士。Avacta Group 的股本回报率为-74.00%，净利润率为-114.45%。股票分析师预测 Avacta Group Plc 在本年度的每股收益将为-9.9011833 便士。</p>
</div><h2>Avacta Group Company Profile</h2>
<div class="lb-trans"><h2>Avacta Group 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics. The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US. Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).</p>
<div class="lb-trans"><p>Avacta Therapeutics 是一家临床阶段的生物制药公司，挑战当前的药物递送方法，以扩大高效癌症治疗药物的应用。该公司受益于世界一流的研发设施、团队中极具才华的科学家以及经验丰富的管理团队，成员分布在伦敦总部和美国。我们的专有 pre|CISION®平台通过将毒性药物结合到一种仅能被肿瘤特异性蛋白酶（成纤维细胞活化蛋白 FAP）切割的短肽上，从而掩盖毒性药物。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Avacta Group</li>
<li>How to Invest in Tech Stocks and Top Tech Stocks to Consider</li>
<li>Why Taiwan Semiconductor's 6.5% Dip Could Be a Smart Buy</li>
<li>5 Top Rated Dividend Stocks to Consider</li>
<li>RTX Surges to Record Highs as Defense Orders Explode</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>Smart Money Is Buying Auto Suppliers, Not Car Brands</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，优于 Avacta Group</li>
<li>如何投资科技股及值得考虑的顶级科技股</li>
<li>为什么台湾半导体的 6.5% 下跌可能是一个明智的买入机会</li>
<li>值得考虑的 5 只高评级分红股票</li>
<li>RTX 因国防订单激增而飙升至历史新高</li>
<li>如何有效使用 MarketBeat 评级筛选器</li>
<li>聪明的钱正在购买汽车供应商，而不是汽车品牌</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Avacta Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Avacta Group 吗？</h2>
</div><p>Before you consider Avacta Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Avacta Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Avacta Group 并不在名单上。</p>
</div><p>While Avacta Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Avacta Group 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Avacta Group (LON:AVCT) 的股价下跌了 14.6% - 以下是原因